65756-27-6

65756-27-6 - Names and Identifiers

Name	1,3-Di-p-tolyl-adamantane
Synonyms	1,3-Di-p-tolyladamantane 1,3-Di-p-tolyl-adamantane 1,3-bis(4-methylphenyl)adamantane 1,3-BIS(4-METHYLPHENYL)ADAMANTANE Tricyclo[3.3.1.13,7]decane, 1,3-bis(4-methylphenyl)-
CAS	65756-27-6
InChI	InChI=1S/C24H28/c1-17-3-7-21(8-4-17)23-12-19-11-20(13-23)15-24(14-19,16-23)22-9-5-18(2)6-10-22/h3-10,19-20H,11-16H2,1-2H3

65756-27-6 - Physico-chemical Properties

Molecular Formula	C24H28
Molar Mass	316.48
Storage Condition	2-8°C

65756-27-6 - Introduction

1,3-Di-p-tolyl-adamantane is an organic compound with the chemical formula C24H28. It has the following properties:

1. Appearance: colorless crystal or white crystalline powder.
2. melting point: about 220-223 degrees Celsius.
3. Boiling point: about 400-410 degrees Celsius.
4. solubility: can be dissolved in organic solvents (such as benzene, dimethylformamide, etc.), and insoluble in water.

The main uses of 1,3-Di-p-tolyl-adamantane include:

1. Chemical research: As an intermediate in organic synthesis, it can be used to synthesize other organic compounds.
2. photoelectric material: it can be used to prepare dyes, fluorescent materials, organic functional materials, etc.
3. Drug field: It can be used as an intermediate or ligand in drug synthesis.

A common method for preparing 1,3-Di-p-tolyl-adamantane is through a fusion reaction. A typical preparation method is to heat-react adamantane with toluene, and then carry out distillation purification to obtain the target product.

Regarding safety information, 1,3-Di-p-tolyl-adamantane will not cause too much safety risk under normal conditions. However, when handling this compound, routine laboratory safety procedures should be followed, including wearing appropriate protective equipment (e. g. gloves, glasses, laboratory coats, etc.). At the same time, avoid contact with the skin and inhalation of its vapors, and ensure that the operation is carried out under well-ventilated conditions. If ingested or inhaled, seek medical attention and inform your doctor about the compound.

Last Update：2024-04-09 21:11:58